Keywords
Last Name
Institution

GAGAN K SOOD

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Surgery
Address6620 Main Stree, Suite 1425
Houston TX 77030
vCardDownload vCard
    Other Positions
    TitleAssociate Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Medicine
    DivisionMedicine-Gastroenterology & Hepatol


    Collapse Additional Tools and Researcher Information 
    Collapse Verify Publications

    Collapse Overview 
    Collapse overview
    Dr. Gagan Sood's primary research focuses on clinical aspects of liver disease, viral hepatitis, portal hypertension and outcome based research in cirrhosis and liver transplantation. His area of main interest is non-alcoholic fatty liver disease (NAFLD/ NASH). He is particularly interested in studying spectrum of NAFLD in different ethnic groups, with focus on genetic and metabolic differences in Hispanic population. Dr. Sood is also interested in iron overload in patient with liver disease including patients with NAFLD. Studies are currently being conducted on non-HFE related genetic markers in patients with primary and secondary iron overload. He is also involved in clinical trials of new anti viral therapies in patients with hepatitis C.

    Collapse keywords
    • Ascites
    • Cirrhosis
    • Colonoscopy
    • Endoscopy
    • Esophagogastroduodenoscopy (EGD)
    • Gastroenterology
    • Hepatic encephalopathy
    • Hepatitis B and C
    • Hepatitis Hemochromatosis
    • Hepatocellular carcinoma
    • Non-alcoholic fatty liver disease (NAFLD)
    • Portal hypertension
    • Varices
    • Wilson's disease


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Tasleem S, Sood GK. Hepatitis C Associated B-cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy. J Clin Transl Hepatol. 2015 Jun 28; 3(2):134-9. PMID: 26357640.
      View in: PubMed
    2. Raza A, Sood GK. Hepatocellular carcinoma review: current treatment, and evidence-based medicine. World J Gastroenterol. 2014 Apr 21; 20(15):4115-27. PMID: 24764650; PMCID: PMC3989948.
    3. Raza A, Mittal S, Sood GK. Interferon-associated retinopathy during the treatment of chronic hepatitis C: a systematic review. J Viral Hepat. 2013 Sep; 20(9):593-9. PMID: 23910642.
      View in: PubMed
    4. Guturu P, Sagi SV, Ahn D, Jaganmohan S, Kuo YF, Sood GK. Capsule endoscopy with PILLCAM ESO for detecting esophageal varices: a meta-analysis. Minerva Gastroenterol Dietol. 2011 Mar; 57(1):1-11. PMID: 21372764.
      View in: PubMed
    5. Parikh M, Singh A, Sood G. Extended treatment duration for treatment naïve chronic hepatitis C genotype 1 late viral responders: a meta-analysis comparing 48 weeks vs 72 weeks of pegylated interferon and ribavirin. J Viral Hepat. 2011 Apr; 18(4):e99-103. PMID: 20950407.
      View in: PubMed
    6. Wickliffe JK, Abdel-Rahman SZ, Lee C, Kormos-Hallberg C, Sood G, Rondelli CM, Grady JJ, Desnick RJ, Anderson KE. CYP1A2*1F and GSTM1 alleles are associated with susceptibility to porphyria cutanea tarda. Mol Med. 2011 Mar-Apr; 17(3-4):241-7. PMID: 20957336; PMCID: PMC3060985.
    7. Rzouq FS, Volk ML, Hatoum HH, Talluri SK, Mummadi RR, Sood GK. Hepatotoxicity fears contribute to underutilization of statin medications by primary care physicians. Am J Med Sci. 2010 Aug; 340(2):89-93. PMID: 20588181.
      View in: PubMed
    8. Gunn GB, Anderson KE, Patel AJ, Gallegos J, Hallberg CK, Sood G, Hatch SS, Sanguineti G. Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: a literature review. Head Neck. 2010 Aug; 32(8):1112-7. PMID: 19536857; PMCID: PMC2891307.
    9. Sagi SV, Mittal S, Kasturi KS, Sood GK. Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials. J Gastroenterol Hepatol. 2010 May; 25(5):880-5. PMID: 20074149.
      View in: PubMed
    10. Hollinger FB, Sood G. Occult hepatitis B virus infection: a covert operation. J Viral Hepat. 2010 Jan; 17(1):1-15. PMID: 20002296.
      View in: PubMed
    11. Singal AK, Singh A, Jaganmohan S, Guturu P, Mummadi R, Kuo YF, Sood GK. Antiviral therapy reduces risk of hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis. Clin Gastroenterol Hepatol. 2010 Feb; 8(2):192-9. PMID: 19879972.
      View in: PubMed
    12. Malhotra A, Naniwadekar A, Sood G. Hepatobiliary and pancreatic: cirrhosis secondary to hepatic sarcoidosis. J Gastroenterol Hepatol. 2008 Dec; 23(12):1942. PMID: 19120880.
      View in: PubMed
    13. Mummadi RR, Kasturi KS, Chennareddygari S, Sood GK. Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2008 Dec; 6(12):1396-402. PMID: 18986848.
      View in: PubMed
    14. Kasturi KS, Mummadi RR, Sood GK. Neutropenic enterocolitis: An unusual complication of HCV combination therapy with PEG-IFN and ribavirin. Eur J Intern Med. 2008 Jul; 19(5):372-3. PMID: 18549944.
      View in: PubMed
    15. van Leeuwen DJ, Sood G, Ferrante D, Lazenby AJ, Sellers MJ. A 38-year-old African-American woman with an unusually rapid progression of "Primary Biliary Cirrhosis": a missed opportunity! Semin Liver Dis. 2002 Nov; 22(4):395-406. PMID: 12447711.
      View in: PubMed
    16. Singal A, Sarin SK, Sood GK, Broor SL. Ulcers after intravariceal sclerotherapy: correlation of symptoms and factors affecting healing. J Clin Gastroenterol. 1990 Jun; 12(3):250-4. PMID: 2362093.
      View in: PubMed
    SOOD's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _